Multiplex Respiratory Virus Testing for Antimicrobial Stewardship: A Prospective Assessment of Antimicrobial Use and Clinical Outcomes Among Hospitalized Adults

J Infect Dis. 2017 Nov 15;216(8):936-944. doi: 10.1093/infdis/jix288.

Abstract

Background: Respiratory tract infections are frequent causes of hospitalization and initiation of empirical antimicrobial therapy. Testing for a broad panel of respiratory viruses has been advocated as a useful tool for antibiotic stewardship. We conducted a prospective observational study to assess the impact of rapid viral test results on antimicrobial prescriptions and clinical outcomes among hospitalized adults.

Methods: Eight hundred patients admitted with respiratory symptoms were tested by a 12-virus respiratory panel (RVP) during 3 consecutive winters in Montreal, Canada. The primary outcome measure was change in antimicrobial prescriptions (ie, de-escalation of empirical antimicrobial therapy or commencement of new antimicrobial therapy) after RVP results were available. Clinical outcomes were also assessed.

Results: Influenza virus was identified in 53% of individuals in the study population, and other viruses were identified in 10%. Influenza virus positivity was associated with shorter duration of hospitalization and appropriate antiviral management. Antibiotic management was most significantly correlated with radiographic suspicion of pneumonia and less so with results of the RVP. Positivity for viruses other than influenza virus was not correlated with significantly different outcomes.

Conclusions: Physicians respond to results of testing for influenza virus when managing hospitalized adult patients but respond less to test results for other viruses. These data can inform the design of stewardship interventions and the selection of viral testing panels for hospitalized patients.

Keywords: adult; antimicrobial stewardship; respiratory virus testing; respiratory viruses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Infective Agents / therapeutic use*
  • Antimicrobial Stewardship*
  • Antiviral Agents / therapeutic use
  • Canada
  • Female
  • Hospitalization
  • Humans
  • Male
  • Middle Aged
  • Multiplex Polymerase Chain Reaction
  • Nasopharynx / virology
  • Prospective Studies
  • Respiratory Tract Infections / diagnosis*
  • Respiratory Tract Infections / drug therapy
  • Respiratory Tract Infections / virology
  • Virus Diseases / diagnosis*
  • Virus Diseases / drug therapy
  • Virus Diseases / virology
  • Viruses / genetics
  • Viruses / isolation & purification*

Substances

  • Anti-Infective Agents
  • Antiviral Agents

Grants and funding